Vertex Pharmaceuticals Inc.
0
0
0%

Financials

Cash flow

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Operating activities 806.9M 842.3M 345.1M 905.2M
Net income 922.9M 880.3M 550.8M 778.1M
Depreciation 46.0M 44.1M 41.2M 39.6M
Deferred taxes -201.0M -97.0M -163.3M 44.0M
StockBased compensation 166.1M 142.6M 141.6M 143.0M
Other non cash items -5.7M 62.0M 20.6M -35.2M
Accounts receivable -51.0M -15.7M -144.5M 58.8M
Accounts payable -30.1M 6.5M 22.3M 7.2M
Other assets liabilities -40.2M -180.5M -123.7M -130.3M
Investing activities -99.7M -412.9M -47.6M -700.5M
Capital expenditures -86.8M -124.2M -34.7M -78.9M
Net intangibles 0 0 0 0
Net acquisitions 219.9M
Purchase of investments -1.1B -1.9B -1.4B -2.1B
Sale of investments 1.1B 1.6B 1.4B 1.2B
Other investing activity 681.8K -3.7M -4.5M -26.3M
Financing activities -990.7M -339.5M -594.1M -362.7M
Long term debt issuance
Long term debt payments -1.2M -1.1M -1.1M -1.1M
Short term debt issuance
Common stock issuance
Common stock repurchase -990.4M -338.9M -593.7M -362.4M
Common dividends
Other financing charges 937.5K 596.6K 681.8K 767.0K
End cash position 4.2B 4.2B 4.0B 3.9B
Income tax paid 408.7M 437.5M 157.2M 231.6M
Interest paid 2.7M 3.0M 2.3M 2.3M
Free cash flow 971.2M 790.4M 663.2M 419.3M
Access the full /cash_flow historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 15 minutes

07:44
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).